Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › GMAB
DEERFIELD MANAGEMENT COMPANY, L.P. position in GMAB
GENMAB A/S · Health Care
DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 6,865,000 shares of GMAB (GENMAB A/S) in its Q2 2026 13F filing — a position valued at US$188.6M, representing 2.36% of its reported portfolio and ranking #9 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed GMAB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DEERFIELD MANAGEMENT COMPANY, L.P.'s GMAB position evolved
DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in GMAB in Q1 2026 at 2,462,000 shares (US$66.1M). The position peaked in Q2 2026 at 6,865,000 shares, worth US$188.6M. Across 2 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,865,000 shares valued at US$188.6M — an increase of 4,403,000 shares quarter over quarter.. Notable position changes include a 179% increase in Q2 2026 (shares rose 30% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 2.46M | $66.06M | New |
| Q2 2026 | 6.87M | $188.58M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 30 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$360.8M), Orbis Allan Gray Ltd (US$312.3M), Sofinnova Investments, Inc. (US$111.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 13.13M sh · $360.77M · Q2 2026
- Orbis Allan Gray Ltd 11.37M sh · $312.28M · Q2 2026
- Sofinnova Investments, Inc. 4.05M sh · $111.12M · Q2 2026
- HARDING LOEVNER LP 3.09M sh · $86.90M · Q2 2026
- Deep Track Capital, LP 3.00M sh · $82.41M · Q2 2026
More on DEERFIELD MANAGEMENT COMPANY, L.P.
FAQ
How long has DEERFIELD MANAGEMENT COMPANY, L.P. held GMAB?
DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed GMAB holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in GMAB?
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 6.87M shares of GMAB (GENMAB A/S), valued at $188.58M, representing 2.36% of its reported portfolio and ranking #9.
Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling GMAB?
In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. increased its position in GMAB. The position peaked in Q2 2026 at 6.87M shares.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, Sofinnova Investments, Inc., among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.